Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2016

01-05-2016 | Research Article

The effect of EGB on proliferation of gastric carcinoma SGC7901 cells

Authors: Y. Qian, L. Xia, W. Shi, JJ. Sun, YQ. Sun

Published in: Clinical and Translational Oncology | Issue 5/2016

Login to get access

Abstract

Objective

To investigate the effect of Ginkgo biloba extract (EGB) on the proliferation and cell cycles of gastric carcinoma SGC7901 cells, and make a preliminary exploration on possible molecular mechanisms associated with its inhibitory effect.

Methods

Human gastric carcinoma SGC7901 cells were cultured in vitro, and treated with various concentrations (100, 200, 300, 400 mg/L) of EGB for different incubation periods (24, 48 and 72 h). CCK-8 assay was used to detect cell proliferation and flow cytometry was performed to analyze the effect of EGB on cell cycles. In addition, mRNA and protein level of two cell cycle regulators cyclin D1 and c-myc in SGC7901 cells treated with EGB were determined using PCR and Western blot. And subcutaneous xenograft model of gastric carcinoma in nude mice was established to evaluate the anti-cancer effect of EGB in vivo.

Results

The proliferation of gastric carcinoma SGC7901 cells was inhibited by EGB in dose- and time-dependent manner. Flow cytometry showed cell cycle arrest in EGB-treated cells, with increased percentage of cells in G1 phase and decreased percentage in S stage. In addition, the mRNA and protein level of cyclin D1 and c-myc genes were significantly down-regulated in cells with EGB treatment with the concentration increasing.

Conclusion

EGB conferred an inhibitory effect on the proliferation of gastric carcinoma SGC7901 cells both in vitro and in vivo. The inhibitory effect was dose dependent and possibly depended on inhibiting cell cycle through G1 arrest induction by suppressing cyclin D1 and c-myc expression.
Literature
1.
Gomez-Martin C, Concha A, Corominas JM, Garcia-Caballero T, Garcia-Garcia E, Iglesias M, et al. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma. Clin Transl Oncol. 2011;13(9):636–51.CrossRefPubMed
2.
Zhou J, Teng XD. Clinicopathologic features of lymphoepithelioma-like gastric carcinoma and literature review. Zhonghua bing li xue za zhi Chin J Pathol. 2013;42(11):758–9.
3.
Zhu X, Li J. Gastric carcinoma in China: current status and future perspectives (review). Oncol lett. 2010;1(3):407–12.PubMedPubMedCentral
4.
Schneider R, Welt K, Aust W, Kluge R, Loster H, Fitzl G. Cardiovascular autonomic neuropathy in spontaneously diabetic rats with and without application of EGb 761. Histol Histopathol. 2010;25(12):1581–90.PubMed
5.
Rodriguez M, Ringstad L, Schafer P, Just S, Hofer HW, Malmsten M, et al. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Atherosclerosis. 2007;192(2):438–44.CrossRefPubMed
6.
Thanoon IA, Abdul-Jabbar HA, Taha DA. Oxidative stress and C-reactive protein in patients with cerebrovascular accident (ischaemic stroke): the role of Ginkgo biloba extract. Sultan Qaboos Univ Med J. 2012;12(2):197–205.CrossRefPubMedPubMedCentral
7.
Zhang Y, Chen AY, Li M, Chen C, Yao Q. Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res. 2008;148(1):17–23.CrossRefPubMedPubMedCentral
8.
Yi SY, Nan KJ, Chen SJ. Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer. Chin J Integr Tradit West Med. 2008;28(1):68–70.
9.
Huang X, Whitworth CA, Rybak LP. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol. 2007;28(6):828–33.CrossRefPubMed
10.
Hauns B, Haring B, Kohler S, Mross K, Unger C. Phase II study of combined 5-fluorouracil/Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer. Phytother Res. 2001;15(1):34–8.CrossRefPubMed
11.
Hyun MH, Lee CH, Kim HJ, Tong Y, Park SS. Systematic review and meta-analysis of robotic surgery compared with conventional laparoscopic and open resections for gastric carcinoma. Br J Surg. 2013;100(12):1566–78.CrossRefPubMed
12.
Chen W, Ouyang XN, Lin QC. Study on the relationship between vascular endothelial growth factor and syndrome type of traditional Chinese medicine in patients with gastric carcinoma. Chin J Integr Tradit West Med. 2007;27(2):127–30.
13.
14.
Zeng JR, Wang CM, Zeng Y, Mo BW, Huang H. Experimental study on the effect of ginkgo bioba extract on the expression of heme oxygenase-1 in bronchial asthma. Chin J Appl Physiol. 2003;19(3):302–5.
15.
Ihl R. Gingko biloba extract EGb 761(R): clinical data in dementia. Int Psychogeriatr. 2012;24(Suppl 1):S35–40.CrossRefPubMed
16.
Shen J, Wang J, Zhao B, Hou J, Gao T, Xin W. Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochim Biophys Acta. 1998;1406(3):228–36.CrossRefPubMed
17.
Gautam J, Kushwaha P, Swarnkar G, Khedgikar V, Nagar GK, Singh D, et al. EGb 761 promotes osteoblastogenesis, lowers bone marrow adipogenesis and atherosclerotic plaque formation. Phytomedicine. 2012;19(12):1134–42.CrossRefPubMed
18.
Hao YR, Yang F, Cao J, Ou C, Zhang JJ, Yang C, et al. Ginkgo biloba extracts (EGb761) inhibits aflatoxin B1-induced hepatocarcinogenesis in Wistar rats. J Chin Med Mater. 2009;32(1):92–6.
19.
Ou C, Zheng HP, Su JJ, Cao J, Li GJ, Li LQ. Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk. Afr Heal Sci. 2014;14(1):37–48.CrossRef
20.
Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem. 2005;280(7):5636–45.CrossRefPubMed
21.
Kim KS, Rhee KH, Yoon JH, Lee JG, Lee JH, Yoo JB. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol. 2005;41(4):383–9.CrossRefPubMed
22.
Pretner E, Amri H, Li W, Brown R, Lin CS, Makariou E, et al. Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761). Anticancer Res. 2006;26(1A):9–22.PubMed
23.
Qi Y, Tu Y, Yang D, Chen Q, Xiao J, Chen Y, et al. Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression. J Cell Physiol. 2007;210(1):63–71.CrossRefPubMed
24.
Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol. 1998;18(8):4499–508.CrossRefPubMedPubMedCentral
Metadata
Title
The effect of EGB on proliferation of gastric carcinoma SGC7901 cells
Authors
Y. Qian
L. Xia
W. Shi
JJ. Sun
YQ. Sun
Publication date
01-05-2016
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2016
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-015-1399-3

Other articles of this Issue 5/2016

Clinical and Translational Oncology 5/2016 Go to the issue

Brief Research Article

Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution

Special Article

Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei)

Research Article

Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985–2012: a population-based study

Research Article

Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer

Research Article

Clinical target volume in postoperative radiotherapy for gastric cancer: identification of major difficulties and controversies

Research Article

The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits